Reported book
$2.3B
13F equity value
Institutional filer · SEC 13F · Q3 2024
The reported 13F portfolio of Saratoga Research & Investment Management (CIK 1477872) - top holdings, how concentrated the book is, and what changed last quarter.
The verdict
Saratoga Research & Investment Management runs a large institutional book - $2.3B across 41 reported positions as of Q3 2024, a moderately concentrated portfolio.
Reflects long US-equity positions reported to the SEC as of Q3 2024; 13F excludes shorts, cash, non-US and most derivatives, so this is not total AUM.
This page reconstructs an institutional manager's reported equity portfolio from its quarterly SEC Form 13F-HR filings. Any investment manager with at least $100 million in qualifying US-listed equity assets must file a 13F with the Securities and Exchange Commission within 45 days of each quarter-end, disclosing the long positions it held on the last day of that quarter. The "reported book" shown here is the total market value of those disclosed positions, it is not the firm's total assets under management, because 13F covers only long US-listed equities and a defined set of options and convertibles. Short positions, cash, private holdings, sovereign debt, most fixed income, non-US equities, and derivatives are all excluded by rule, so a manager's true economic exposure can differ materially from what appears here. "Positions" counts the distinct securities disclosed; "% of book" shows how much weight each holding carries. Treat these figures as a quarter-lagged snapshot for understanding how a manager is positioned - not as live holdings or investment advice. Each line traces back to a specific filing on SEC EDGAR. This page is provided for informational purposes only and is not financial advice, consult a licensed financial advisor before making investment decisions.
Reported book
$2.3B
13F equity value
Positions
41
Disclosed securities
Top-5 weight
35%
Of reported book
Largest position
7.7%
RTX Corp.
The five largest positions make up about 35% of Saratoga Research & Investment Management's reported book as of Q3 2024.
| # | Security | Value | % of book |
|---|---|---|---|
| 1 | RTX Corp. | $176.8M | 7.7% |
| 2 | Unilever PLC | $169.4M | 7.4% |
| 3 | Microsoft Corp. | $154.7M | 6.8% |
| 4 | Alphabet Inc. | $154.7M | 6.8% |
| 5 | Berkshire Hathaway Inc. | $150.3M | 6.6% |
| 6 | Walt Disney Company | $147.7M | 6.5% |
| 7 | Oracle Corp. | $136.4M | 6.0% |
| 8 | Medtronic PLC | $122.1M | 5.3% |
| 9 | Roche Holdings, Ltd. | $92.9M | 4.1% |
| 10 | Johnson & Johnson | $86.3M | 3.8% |
| 11 | Novo Nordisk A/S | $84.4M | 3.7% |
| 12 | Apple Inc. | $77.4M | 3.4% |
| 13 | General Dynamics Corporation | $72.9M | 3.2% |
| 14 | Nike, Inc. | $62.7M | 2.8% |
| 15 | Home Depot Inc. | $60.2M | 2.6% |
| 16 | Accenture PLC | $57.9M | 2.5% |
| 17 | C.H. Robinson Worldwide Inc | $57.1M | 2.5% |
| 18 | Starbucks Corp. | $53.5M | 2.3% |
| 19 | Diageo PLC | $51.5M | 2.3% |
| 20 | Visa Inc | $50.7M | 2.2% |
| 21 | Walmart Inc | $39.5M | 1.7% |
| 22 | Adobe Inc | $39.1M | 1.7% |
| 23 | Pepsico Inc | $29.8M | 1.3% |
| 24 | The Procter & Gamble Co. | $29.5M | 1.3% |
| 25 | Biogen Inc | $29.2M | 1.3% |
Reading Saratoga Research & Investment Management's book
A concentrated core with a diversified tail.
Informational only, not investment advice. 13F is a 45-day-lagged quarterly snapshot; positions may have changed since the filing date.
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2024 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.